Last Updated on September 7, 2024 by The Health Master
FDA Maharashtra
The Food and Drug Administration Maharashtra (FDA Maharashtra) has launched a comprehensive statewide inspection campaign to address the growing concern of general practitioners engaging in illegal drug sales.
In response to complaints from the Maharashtra State Chemists and Druggists Association, the FDA Maharashtra is taking a proactive approach to curb this practice, which not only violates regulations but also poses risks to patient safety.
Illegal Drug Sales: A Growing Concern
The Maharashtra State Chemists and Druggists Association reported receiving numerous complaints from district bodies about doctors stockpiling and selling drugs in large quantities.
This practice, potentially violating Schedule K of the Drugs and Cosmetics Rules, 1945, has raised serious concerns about the integrity of the healthcare system.
FDA Maharashtra: Inspection Drive
To address this issue, the FDA Maharashtra has mandated that each drug inspector visit at least 10 general practitioners.
The inspections are aimed at identifying unlicensed practitioners and verifying the purchase bills of medications stocked for patient use.
While no violations have been detected so far, the FDA Maharashtra remains vigilant in its investigation.
Preventing Unauthorized Distribution Channels
In addition to the inspections, the FDA Maharashtra is conducting random audits of wholesalers to cross-reference drug sales records with those of individual general practitioners.
This helps identify any unauthorized distribution channels and prevent drugs from falling into the wrong hands.
Impact on Retailers
The illegal storage and sale of drugs by general practitioners have significant implications for retailers in the pharmaceutical industry.
As Anil Belkar, secretary of the Pune District Chemists’ Association, pointed out, “This issue of illegal storage and sale of drugs in large quantities by doctors has been discussed in detail at our executive meetings.
It is a serious concern affecting the professional lives and future of many retailers.”
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA issues warning letter to Brassica Pharma, Maharashtra
Fire breaks out at Pharma Plant in Maharashtra
Maharashtra FDA conducts raids at three different locations in Vasai
FDA Maharashtra: Two Agencies Accused of Distributing Spurious Drugs
No More Discount Banners for Pharmacies in Maharashtra
FDA Maharashtra: Two Agencies Accused of Distributing Spurious Drugs
Pharma Industry seeks amendments to DPCO 2013
Telangana DCA Busts Illegal Drug Trade in Hyderabad
Drug recall: Dr Reddy’s, Lupin recall drugs over quality issue
Pharma Companies Under Scrutiny: New Rules for Marketing Practices
DCGI granted approval for Eye Drops to treat Presbyopia
Pakistan: Drug Production Quality Under Scrutiny, Concerns Raised in Senate Committee
NDPS: Illegal Drug Manufacturing Unit busted in East Godavari
USFDA issues EIR for Marksans Pharma Goa facility
Indian Pharma Industry: A Global Powerhouse
USFDA approval granted for generic drug for Scalp Psoriasis Treatment
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
